Chlamydia, Gonorrhea and Trichomoniasis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants Participants aged 18 years and above /or mature minors* Individuals suspected of/at high risk of having STIs, based on either syndromic or behavioural risk assessments. Willing to provide 3 vaginal swabs (women) or 1 penile meatal swab and 1 first catch urine (men) sample for STI testing Willing and able to provide voluntary written informed consent Health facilities A level 5, 4 or 3 public health facility within Kilifi or Nairobi which has all the following: MCH/FP, ANC, OPD/STI Clinics, and a CCC GeneXpert onsite or having an established sample transport to a nearby testing lab with GeneXpert Health facilities with higher STI caseloads Or a drop-in centre (DIC) & private pharmacy providing clinical services including STI screening and treatment Or a private pharmacy providing clinical services including STI screening and treatment
Exclusion criteria
Exclusion criteria: Participants Individuals undergoing antimicrobial therapy for STI at the time of sample collection Clients who have used a vaginal cream or ointment product; douched; or used spermicides, vaginal lubricants; or used traditional products (e.g., herbs or drying agents) for cleaning inside the vagina within 48 hours (about 2 days) of testing Participants unwilling or who decline to provide voluntary written informed consent to participate in the study. Health facilities Facilities not willing to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CT: Sensitivity, specificity, PPV, NPV NG: Sensitivity, specificity, PPV, NPV TV: Sensitivity, specificity, PPV, NPV ;·Feasibility: Ease and implementation of sample collection, same day sample processing, same day result communication, same day treatment initiation, partner notification, partner return; Aptitude MetrixTM result interpretation; error/invalid rates ·Acceptability to facility staff: Client/provider feedback on sample collection, incorporating STI testing (both POC and non-POC) in clinic workflow, ease of use of Aptitude MetrixTM by provider ·Acceptability to clients: willingness to provide sample, wait for same day test result, disclose test result to partner, pay for service ·Impact of POC testing: STI client load, testing volume, testing coverage, treatment initiation and completion rates, partner notification rates, partner return rates ·Operationalization: changes to clinic workflow, provider experience, client experience | — |
Secondary
| Measure | Time frame |
|---|---|
| Prevalence of chlamydia, gonorrhea and trichomonas | — |
Countries
Kenya
Contacts
Technical Lead